Kevin Bellofatto, Switzerland

Kevin Bellofatto, Ph.D., is a postdoctoral researcher at the University of Geneva’s Cell Isolation and Transplantation Centre, Department of Surgery. His work focuses on tissue engineering for cell therapy in Type 1 diabetes, combining expertise in human placental matrix-derived scaffolds, amniotic membrane hydrogels, pancreatic islet isolation, and organoid transplantation. He holds a Ph.D. in Histology and Health Sciences from Università del Piemonte Orientale and has collaborated in research projects on hepatocyte co-transplantation and hemophilia gene therapy. He is accredited for GMP cell isolation and animal research studies. Bellofatto has contributed to more than fifteen scientific publications and actively mentors undergraduate and graduate students in cell biology and engineering.